Literature DB >> 20190824

Resistance to and synthesis of the antibiotic mupirocin.

Christopher M Thomas1, Joanne Hothersall, Christine L Willis, Thomas J Simpson.   

Abstract

Mupirocin, a polyketide antibiotic produced by Pseudomonas fluorescens, is used to control the carriage of methicillin-resistant Staphylococcus aureus on skin and in nasal passages as well as for various skin infections. Low-level resistance to the antibiotic arises by mutation of the mupirocin target, isoleucyl-tRNA synthetase, whereas high-level resistance is due to the presence of an isoleucyl-tRNA synthetase with many similarities to eukaryotic enzymes. Mupirocin biosynthesis is carried out by a combination of type I multifunctional polyketide synthases and tailoring enzymes encoded in a 75 kb gene cluster. Chemical synthesis has also been achieved. This knowledge should allow the synthesis of new and modified antibiotics for the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190824     DOI: 10.1038/nrmicro2278

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  58 in total

1.  Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus.

Authors:  Martin Antonio; Neil McFerran; Mark J Pallen
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  The chemistry of pseudomonic acid. 17. Dual-action C-1 oxazole derivatives of pseudomonic acid having an extended spectrum of antibacterial activity.

Authors:  N J Broom; R Cassels; H Y Cheng; J S Elder; P C Hannan; N Masson; P J O'Hanlon; A Pope; J M Wilson
Journal:  J Med Chem       Date:  1996-08-30       Impact factor: 7.446

3.  Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Eileen Ingham; Colin Fishwick; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Tandemly duplicated acyl carrier proteins, which increase polyketide antibiotic production, can apparently function either in parallel or in series.

Authors:  Ayesha S Rahman; Joanne Hothersall; John Crosby; Thomas J Simpson; Christopher M Thomas
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

Review 5.  Isoprenoid-like alkylations in polyketide biosynthesis.

Authors:  Christopher T Calderone
Journal:  Nat Prod Rep       Date:  2008-06-18       Impact factor: 13.423

6.  Characterization of the mupirocin biosynthesis gene cluster from Pseudomonas fluorescens NCIMB 10586.

Authors:  A Kassem El-Sayed; Joanne Hothersall; Sian M Cooper; Elton Stephens; Thomas J Simpson; Christopher M Thomas
Journal:  Chem Biol       Date:  2003-05

7.  Mupirocin resistance screening of methicillin-resistant Staphylococcus aureus isolates at Madigan Army Medical Center.

Authors:  Dana Perkins; Jacob S Hogue; Mary Fairchok; LoRanée Braun; Helen B Viscount
Journal:  Mil Med       Date:  2008-06       Impact factor: 1.437

8.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Authors:  R Sutherland; R J Boon; K E Griffin; P J Masters; B Slocombe; A R White
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 9.  Mupirocin resistance.

Authors:  Jean B Patel; Rachel J Gorwitz; John A Jernigan
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

10.  Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella typhimurium.

Authors:  Wilhelm Paulander; Sophie Maisnier-Patin; Dan I Andersson
Journal:  Mol Microbiol       Date:  2007-05       Impact factor: 3.501

View more
  51 in total

Review 1.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

2.  Enzymatic basis of "hybridity" in thiomarinol biosynthesis.

Authors:  Zachary D Dunn; Walter J Wever; Nicoleta J Economou; Albert A Bowers; Bo Li
Journal:  Angew Chem Int Ed Engl       Date:  2015-02-26       Impact factor: 15.336

3.  Insights into physiological and genetic mupirocin susceptibility in bifidobacteria.

Authors:  Fausta Serafini; Francesca Bottacini; Alice Viappiani; Enrico Baruffini; Francesca Turroni; Elena Foroni; Tiziana Lodi; Douwe van Sinderen; Marco Ventura
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

Review 4.  Biased gene transfer in microbial evolution.

Authors:  Cheryl P Andam; J Peter Gogarten
Journal:  Nat Rev Microbiol       Date:  2011-06-13       Impact factor: 60.633

5.  Silencing of Essential Genes within a Highly Coordinated Operon in Escherichia coli.

Authors:  Shan Goh; Angela Hohmeier; Timothy C Stone; Victoria Offord; Francisco Sarabia; Cristina Garcia-Ruiz; Liam Good
Journal:  Appl Environ Microbiol       Date:  2015-06-12       Impact factor: 4.792

6.  Enzyme-Catalyzed Intramolecular Enantioselective Hydroalkoxylation.

Authors:  Shu-Shan Gao; Marc Garcia-Borràs; Joyann S Barber; Yang Hai; Abing Duan; Neil K Garg; K N Houk; Yi Tang
Journal:  J Am Chem Soc       Date:  2017-03-01       Impact factor: 15.419

Review 7.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 8.  Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.

Authors:  Christopher S Francklyn; Patrick Mullen
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

Review 9.  Emergence and evolution.

Authors:  Tammy J Bullwinkle; Michael Ibba
Journal:  Top Curr Chem       Date:  2014

10.  Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

Authors:  I G Azcárate; P Marín-García; N Camacho; S Pérez-Benavente; A Puyet; A Diez; L Ribas de Pouplana; J M Bautista
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.